v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income (loss) $ 318,509 $ (3,474,531)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Amortization 1,017,811
Common stock issued for services 85,150 117,611
Stock compensation expense 4,365,000 1,752,000
Units in unconsolidated affiliate for services (830,295)
Change in fair value of investment in unconsolidated affiliate (3,576,141)
Non-cash lease expense 22,390
Changes in operating assets and liabilities:    
Accounts receivable (2,500,000)
Prepaid expenses and other assets (9,251) 60,606
Accounts payable and accrued liabilities (673,129) 194,649
Accounts payable and accrued liabilities – related parties (1,016,725) 562,975
Deposits (15,321)
Operating lease liabilities (5,247)
Deferred revenue (1,193,500)
Net cash used in operating activities (4,010,749) (786,690)
Cash flows from financing activities:    
Cash from sale of common stock, pre-funded warrants and warrants 13,600,270
Cost of financing (1,346,157)
Proceeds from (payments to) short term loan – related parties (825,700) 825,700
Deferred offering costs (121,010)
Net cash provided by financing activities 11,428,413 704,690
Net increase (decrease) in cash and cash equivalents 7,417,664 (82,000)
Cash and cash equivalents at beginning of period 401,203 156,087
Cash and cash equivalents at end of period 7,818,867 74,087
Supplementary disclosure of non-cash operating, investing and financing activities:    
Common stock issued for accounts payable 103,401
Operating lease right-of-use assets in exchange for operating lease liabilities 340,273
Deferred offering costs charged to cost of financing in equity upon completion of the February 2026 offering 393,203
Noncash offering cost - underwriter warrants issued in February 2026 offering $ 298,945

Source